Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial (BRAVO)

NCT01936857 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01936857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01936857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial (BRAVO)
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2015
Completion date
April 30, 2019
Enrollment
281 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, substance related disorders